secwatch.observer — SEC 8-K summary
======================================

Issuer:     ALX ONCOLOGY HOLDINGS INC (ALXO)
CIK:        0001810182
Form:       8-K
Filed at:   2024-06-17T23:59:59+00:00
Accession:  0000950170-24-074258
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

ALX Oncology annual meeting results: all three director nominees elected, proposals approved
--------------------------------------------------------------------------------

- Corey Goodman, Jason Lettmann, Sophia Randolph elected as Class I directors for terms until 2027.
- Advisory vote on executive compensation approved: 40,935,354 for, 1,422,239 against, 34,391 abstain.
- Ratification of KPMG as independent auditor for FY 2024 approved: 47,698,670 for, 11,338 against, 2,733 abstain.
- Broker non-votes: 5,320,757 on director elections and advisory compensation vote.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1810182/000095017024074258/0000950170-24-074258-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1810182/000095017024074258/alxo-20240612.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-074258

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer